Bridging the gap between marketed products and unmet medical needs
Reformulation, repurposing and novel drug delivery (NDDS) of existing dosage forms and active pharmaceutical ingredients, delivered from our R&D site in Ahmedabad, India.
- Powder for injection
- RTU infusion bags
- Pre-filled syringes
- Lyophilized products
- Ophthalmic solutions & suspensions
- Oral liquids
- Liposomal injections
- Solvent free nanosuspensions
- Biodegradable depot injections
Innovative. Competitive. Timely bound.
Auxilla Pharmaceuticals and Research LLP was founded in early 2019 with the idea of filling the gap between existing marketed products and unmet medical needs, such as dosage regimen, formulation challenges, and safety and efficacy issues, to improve patient compliance.
Our site has been developed within the framework of ICH/WHO guidelines and is located in Ahmedabad, a global hub of pharmaceuticals. We combine expertise, state-of-the-art infrastructure and diverse experience to provide pharmaceutical formulation development solutions for various dosage forms.
A track record built across regulated markets
Formulation and analytical development under one roof
Formulation Development
- Injectable formulations
- Ophthalmic and liquid oral formulations
- Liposomal and microsphere-based formulations
Analytical Development
- Method development and validation
- Stability studies
- Impurity profiling
Quality Assurance & Documentation
- SOP and protocol documentation
- Development report preparation
- Deviation and CAPA management
Microbiology
- Sterility and bacterial endotoxin testing
- Microbial limit and bioburden testing
- Environmental and cleanroom monitoring
Sterile and non-sterile dosage forms
From powder for injection and lyophilized products to ophthalmics and oral suspensions, our development experience spans the dosage forms where formulation challenges matter most.
Sterile Injectables
Powder for injection, RTU infusion bags, pre-filled syringes, lyophilized products
Ophthalmic Formulations
Ophthalmic solutions and suspensions
Oral Liquids
IR solutions, IR suspensions and SR suspensions
Complex Generics & NDDS
Liposomal, microsphere-based and long-acting platforms
Four pillars behind every project
Idea: Innovative
Reformulation, repurposing and NDDS that address gaps left by existing marketed products.
Team: Competitive
A 70-member team spanning formulation, analytical, QA, RA, BD and project management.
Positioning: Difference
A focus on complex sterile and non-sterile dosage forms and platform technologies.
Delivery: Timely bound
Focused, time-sensitive project delivery in product development services.
Three ways to work with us
Contract research services
- 14 clients from EU/US
- 3 products approved in US and 3 in EU
- 24 products technology transferred
Co-development projects
- 6 clients from EU/US/India
- 3 products for US market filed in 2024
- 1 product filed in EU in 2024
In-house developed projects for out-licensing
- 1 complex liposomal injection
- 6 RTU long acting injections
- 1 RTU and 1 PFS injection
An R&D site developed within the ICH/WHO framework
Our Sanand, Ahmedabad facility brings formulation, stability, analytical and microbiology work together, with dedicated general and potent areas for parenteral and liquid development.
- Parenteral and liquid formulation labs (general and potent)
- Dedicated stability area
- Analytical development lab with 18 HPLCs
- Microbiology lab with airlocks, MLT and media preparation rooms
Serving clients across the EU, US and India
Innovative. Competitive. Timely bound. Start your formulation project with Auxilla.